Yahoo Poland Wyszukiwanie w Internecie

Zaloguj się

Search results

  1. www.who.int › publications › iLaboratory biosafety guidance related to coronavirus disease...

    28 sty 2021 · The purpose of this document is to provide interim guidance on laboratory biosafety related to the SARS-CoV-2 virus to laboratories and stakeholders involved in COVID-19 laboratory work.

  2. apps.who.int › iris › bitstreamLaboratory biosafety guidance related to coronavirus disease...

    Laboratory biosafety guidance related to coronavirus disease (COVID-19) Interim guidance 28 January 2021. Background. The purpose of this document is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patients. Highlights of SARS-CoV-2 laboratory biosafety.

  3. www.who.int › docs › default-sourceLaboratory biosafety guidance related to the novel coronavirus...

    Interim guidance. 12 February 2020. 1. Introduction. The purpose of this document is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patient that meet the case definition of the novel pathogen identified in Wuhan, China, i.e. 2019 novel coronavirus (2019-nCoV), the disease named COVID-19. .

  4. www.who.int › publications › iLaboratory biosafety guidance related to SARS-CoV-2 (COVID-19):...

    11 mar 2024 · Interim guidance on laboratory biosafety related to the SARS-CoV-2 virus to laboratories and stakeholders involved in COVID-19 laboratory work.

  5. www.cdc.gov › covid › phpInterim Guidelines for Biosafety and COVID-19

    10 lip 2024 · Key points. For guidance on point-of-care testing, see the Guidance for SARS-CoV-2 Point-of-Care and Rapid Testing. All laboratories should perform a site-specific and activity-specific risk assessment and follow Standard Precautions when handling clinical specimens. See Biological Risk Assessment: General Considerations for Laboratories.

  6. www.degruyter.com › document › doiLaboratory work safety rules and guidelines during COVID-19...

    Effective healthcare functioning depends on laboratory professionals who provide diagnostic tests that allow practitioners to confirm COVID-19 and monitor the health status of patients affected by the disease who are also suffering from many other diseases.

  7. cdn.who.int › media › docsWHO Laboratory biosafety guidance related to coronavirus disease...

    29 kwi 2021 · Overview of Key Points. Good Microbiological Practice and Procedure. Biological Risk Assessment. Clinical testing (non-propagative) Culture and isolation of SARS-CoV-2. Transport and shipping. Disinfection, inactivation, waste management. Good Microbiological Practice and Procedure (GMPP)